The largest database of trusted experimental protocols

12 protocols using indomethacine

1

Electrochemical Synthesis of Drug-Loaded Polypyrrole Films

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug containing PPy films were grown potentiostatically onto the device electrodes using a Bio-Logic SP-150 potentiostat. The dexamethasone electrosynthesis solution consisted of 0.2 M Pyrrole (Alfa Aesar, Ward Hill, MA) and 0.02 M dexamethasone 21 phosphate disodium salt (Sigma-Aldrich, used as received) in Milli-Q water of 18 MΩ/cm resistivity. The Indomethacine electrosynthesis solution consisted of 0.2 M Pyrrole and 0.01 M Indomethacin (Sigma-Aldrich) in acetonitrile. The acetylsalicylic acid electrosynthesis solution consisted of 0.2 M Pyrrole (Alfa Aesar, Ward Hill, MA) and 0.02 M acetylsalicylic acid (Sigma-Aldrich,) in Milli-Q water. The films were synthesized by applying a constant current of 0.1 mA for Indomethacin and 1 mA for acetylsalicylic acid and dexamethasone each for 10 minutes between the drug release electrode and the counter electrode. For drug release experiments, the counter and working electrodes were reversed. The amount of released DEX, ASA and Indomethacin was quantified by absorbance at 242 nm, 298 nm and 318 nm, respectively using an infinite M200 Pro plate reader (TECAN).
+ Open protocol
+ Expand
2

Adipogenic Differentiation of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were seeded with 35,000 cells per well in 24 well plates (Nunclon Surface, Sigma Aldrich, Schnelldorf, Germany) in adipogenic induction medium and cultured for 14 days (n = 2-4 assays per donor). Adipogenic differentiation medium consisted of DMEM HG (Invitrogen, Karlsruhe, Germany), 10% FCS (Invitrogen, Karlsruhe, Germany), 1 mM dexamethasone, 0.2 mM indomethacine, 0.5 mM isobutyl methylxanthine (all Sigma-Aldrich, Schnelldorf, Germany) 0.01 mg/ml insulin glargin (Sanofi-Aventis, Frankfurt, Germany) and 1% penicilline/streptomycine (Biochrom, Berlin, Germany).
Adipogenic differentiation was assessed by fixation with 4% paraformaldehyde and staining with 0.3% Oil Red O solution (Chroma, Münster, Germany). Evaluation of adipogenic differentiation was conducted by a qualitative microscopic assessment of lipid vacuole formation.
+ Open protocol
+ Expand
3

Adipogenic and Osteogenic Differentiation Assay for MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATMSC was seeded at a number of 1×105cells/well in a 4-well plate in MSC culture medium. After getting 100% confluency, the culture medium was changed to adipogenic or osteogenic differentiation medium. The culture medium was changed twice per week for 3 weeks. Adipogenic differentiation medium consisted of IMDM supplemented with 10% FBS, 0.1 mM dexamethasone (Sigma-Aldrich), 0.5 mM 3-isobutyl-1-methylxanthine (Sigma-Aldrich), 2 mg/mL insulin (Wako), and 0.1 mM indomethacine (Sigma-Aldrich). The formation of adipocytes was examined by staining with Oil Red O solution (Muto Pure Chemicals, Tokyo, Japan). For quantification, cells were dissolved with 4% IGPAL CA630 (Sigma-Aldrich) in isopropanol, and the absorbance at 492 nm was measured. Osteogenic differentiation medium consisted of IMDM supplemented with 1% FBS, 0.1 mM dexamethasone (Sigma-Aldrich), 10 mM β-glycerol-2-phosphate (Sigma-Aldrich), 0.2 mM ascorbic acid (Sigma-Aldrich), and 50 ng/mL human EGF (Wako). The formation of mineralized matrix was examined by staining with Alizarin Red S (Kodak, Rochester, NY). For quantification, cells were dissolved with 0.2 N HCl (Wako) and 5% sodium dodecyl sulfate, then the absorbance at 480 nm was measured.
+ Open protocol
+ Expand
4

Adipogenic Induction of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After expansion, MSC were subjected to adipogenic induction medium consisting of DMEM high glucose, 10% FCS, 1 μm dexamethasone, 0.2 mM indomethacine, 0.5 mM isobutylmethylexanthine (all Sigma, Deisenhofen, Germany), 0.01 mg/ml insulin (Sanofi-Aventis, Frankfurt, Germany), 100 units/ml penicillin, and 100 μg/ml streptomycin. Cells were cultured for 3 weeks with medium changed twice per week. To monitor adipogenesis, cells were fixed with 4% paraformaldehyde and stained with 0.3% Oil Red O solution (Chroma, Münster, Germany). Dye was re-extracted from vacuoles by 60% isopropanol and quantified by measuring its optical density at 490 nm.
+ Open protocol
+ Expand
5

Adipose-Derived Mesenchymal Stem Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adipose-Derived human Mesenchymal Stem Cells (AD-hMSCs, Lifeline Cell Technology, Frederick, MD, USA) were expanded at 37°C and 5% CO2 in Mesenchimal Stem Cell Growth Medium 2, supplemented with Mesenchymal Stem Cell Growth Medium 2 Supplement Mix (PromoCell, Heidelberg, Germany). For differentiation experiments, confluent cells were switched to Mesenchymal Stem Cell Growth Medium 2 supplemented with 10% Foetal Bovine Serum (Biowest #S1810-500, Nuaillé, France), 0.2 μΜ Indomethacine (Sigma-Aldrich, #I7378), 10 μg/ml insulin (Sigma-Aldrich #I2643), 1 μM dexamethasone (Sigma-Aldrich #D2915), and 0.5 mM Isobutylmethylxanthine (Sigma-Aldrich, #I7018), to induce the differentiation into adipocytes. Medium was replenished every three days. For cell growth measurements, cells were detached with TrypLE Express (Gibco, #12304-021, Thermofisher) and were counted with a Cell Countess II FL (Thermo-Fisher Scientific).
+ Open protocol
+ Expand
6

Evaluating Vasoactive Effects of H. stoechas Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
The preparation of methanolic H. stoechas extract was previously described [12 (link)], and a plant voucher was deposited at the Universidad San Jorge herbarium (ref. 002–2014). The phenolic profile of this extract was previously determined [12 (link)] (see Introduction).
The compositions of the buffers used were as follows: Krebs buffer (in millimolar): NaCl 120, KCl 4.7, CaCl2 2.4, MgSO4 1.2, NaHCO3 24.5, KH2PO4 1, and glucose 5.6. Ca2+-free Krebs: NaCl 120, KCl 4.7, CaCl2 2.40, MgSO4 1.2, NaHCO3 24.5, KH2PO4 1, glucose 5.6, and ethyleneglycoltetraacetic acid (EGTA) 1. Ca2+-free high K+ Krebs ([K+]o = 50 mM). All buffers were adjusted to pH 7.4. Apamin (AP), arzanol, barium chloride dihydrate (BaCl2), glibenclamide (Glib), heparin (H), H-89 dihydrochloride hydrate, indomethacine, Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME), phenylephrine (PE), ruthenium red (RR) and verapamil (V) were obtained from Sigma (Madrid, Spain).
Tetraethylammonium (TEA), 1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole (TRAM-34) and Rp-8-Br-PET-cGMPS were purchased from Tocris (Madrid, Spain). AP was diluted in acetic acid. Glib, TRAM-34 and arzanol were dissolved in dimethyl sulfoxide (DMSO). All other chemicals were dissolved in distilled water.
+ Open protocol
+ Expand
7

Adipogenic Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s Modified Eagle’s Medium, alpha Modified Eagle’s Medium, Cosmic Calf Serum and Fetal Bovine Serum (FBS) were from Life Technologies. GW4064 was from Tocris. Ascorbic acid, β-glycerophosphate, bovine insulin, IBMX, dexamethasone, indomethacine, pioglitazone and rosiglitazone were from Sigma.
+ Open protocol
+ Expand
8

Adipogenic and Osteogenic Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
First-passage ASCs were replated on thermanox cover slips (Nunc, Roskilde, Denmark) for adipogenic differentiation, and another part for osteogenic differentiation. Adipogenic differentiation was performed using basic culture medium with addition of dexamethasone, insuline, indomethacine and 3-isobutyl-1-methylxanthine (Sigma-Aldrich, St Louis, MO, USA). Differentiation was confirmed by Oil Red O stain. Osteogenic differentiation was performed using basic culture medium with addition of dexamethasone, ascorbic acid and β-glycerophosphate (Sigma-Aldrich, St Louis, MO, USA). Differentiation was confirmed by Von Kossa's Stain. Digital imaging of all wells was performed using an Olympus inverted microscope, and Cell^M software (Olympus Europe, Hamburg, Germany).
+ Open protocol
+ Expand
9

Systematic Evaluation of Pharmaceuticals

Check if the same lab product or an alternative is used in the 5 most similar protocols
Celecoxib was purchased from Astatech Inc. (Bristol, PA, USA), while cinnarizine, JNJ-2A, ibuprofen, and itraconazole were obtained from Janssen Pharmaceutica (Beerse, Belgium). Fenofibrate and indomethacine were purchased from Sigma-Aldrich (Wicklow, Ireland). Progesterone, felodipine, sulfalazine, haloperidol, danazol, naproxen, venetoclax, carvedilol, dipyridamole, niclosamide, griseofulvin, fenofibric acid, ketoconazole, and clotrimazole were purchased from Kemprotec (Carnforth, UK), and Capmul MCM C8 was kindly donated by Abitec (Columbus, OH, USA). Maisine CC was a kind gift from Gattefossé (Lyon, France). All other chemicals and solvents were of analytical or high-performance liquid chromatography (HPLC) grade, purchased from Sigma-Aldrich (Wicklow, Ireland).
+ Open protocol
+ Expand
10

Osteoblastic Differentiation of GMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMSCs were purchased from Cyagen Biosciences as osteoblast progenitors (OBPs). OBPs were cocultured with GMSCs (GMSCs to OBPs = 1:10) in a Transwell system using the StemPro Osteogenesis Diff Kit (Gibco), according to the manufacturer’s protocol. Calcification was verified by alizarin red staining.
To determine GMSC osteogenesis function, GMSCs were induced using the StemPro Osteogenesis Diff Kit (Gibco), according to the manufacturer’s protocol. Calcification was verified by alizarin red staining. Quantification was solubilized by 100 mM hexadecyl pyridinium chloride monohydrate for 30 min and measured at 540 nm. To determine underlying molecular mechanisms in different groups, GMSCs were pretreated with the CD39 inhibitor (POM-1), indoleamine-2,3-dioxygenase (IDO) inhibitor (1-methyl-L-tryptophan [1-MT]; Sigma-Aldrich; 500 μM), p38 inhibitor (SB203580; Sigma-Aldrich; 10 μM), activin receptor-like kinase 5 (ALK5) inhibitor (LY364947; Sigma-Aldrich; 20 μM), selective cyclooxygenase 1 (COX-1) inhibitor (indomethacine; Sigma-Aldrich; 20 μM), or selective COX-2 inhibitor (NS-398; Sigma-Aldrich; 20 μM).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!